Literature DB >> 28559986

Severe traumatic hemorrhagic shock induces compromised immune barrier function of the mesenteric lymph node leading to an increase in intestinal bacterial translocation.

Jian Zhang1,2, Yun Zhang1,2, Tao Xu1,2, Sheng-Jing Pan1,2, Gang Nie1,2, Xiao-Yan Miao1, Jun-Yu Qiu1,2, Wen-Qiao Yu1,2, Shao-Yang Zhang1,2, Ting-Bo Liang1,2,3.   

Abstract

Critically ill patients have increased susceptibility to translocation of gut bacteria. However, the mechanisms are complicated and remain unclear, and the aim of this study was to explore these mechanisms. Rats exposed to different levels of shock were orally administrated with bioluminescent Citrobacter. We found that severe shock caused an increase in bacterial translocation to the visceral organs, such as liver, spleen and blood, compared with mild shock. Surprisingly, bacterial translocation to mesenteric lymph node (MLN) was unchanged between the two shock groups. Various methods, including flow cytometry, a co-culture model and western blots, were used to evaluate MLN-associated immune function. Specifically, we focused on mesenteric lymph node dendritic cells (MLN-DCs), the critical antigen presenting cells involved in the construction of the immune barrier in MLN. We also found that severe shock impaired the phenotypic maturation of MLN-DCs and induced a tolerogenic phenotype. Furthermore, co-culture assays of DCs with naive CD4+ T cells showed that DCs subject to severe shock were more inclined to polarize native CD4+ T cells into Th2 and Treg cells. This study successfully reproduced the clinical phenomenon of severe shock resulting in increased bacterial translocation to extraintestinal tissues, and this may be related to the compromised immune barrier function of MLN, as maturation and function of MLN-DC's were badly impaired.

Entities:  

Keywords:  T cell polarization; Traumatic hemorrhagic shock; intestinal bacterial translocation; intestinal immune barrier; mesenteric lymph node dendritic cells

Year:  2017        PMID: 28559986      PMCID: PMC5446518     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  28 in total

Review 1.  The inflammatory response in sepsis.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Trends Immunol       Date:  2012-10-02       Impact factor: 16.687

2.  Resuscitation with hydroxyethyl starch solution prevents bone marrow mononuclear apoptosis in a rat trauma-hemorrhagic shock model.

Authors:  Liang Liang; Guodong Xu; Yun Zhang; Wei Chen; Junjiang Li; Tingbo Liang
Journal:  J Trauma       Date:  2010-03

3.  Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium.

Authors:  Siouxsie Wiles; Simon Clare; James Harker; Alan Huett; Douglas Young; Gordon Dougan; Gad Frankel
Journal:  Cell Microbiol       Date:  2004-10       Impact factor: 3.715

4.  Adoptive transfer of T lymphocytes to T-cell-depleted mice inhibits Escherichia coli translocation from the gastrointestinal tract.

Authors:  M D Gautreaux; F B Gelder; E A Deitch; R D Berg
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

5.  Increased iNOS activity is essential for intestinal epithelial tight junction dysfunction in endotoxemic mice.

Authors:  Xiaonan Han; Mitchell P Fink; Runkuan Yang; Russell L Delude
Journal:  Shock       Date:  2004-03       Impact factor: 3.454

6.  Allicin, a major component of garlic, inhibits apoptosis in vital organs in rats with trauma/hemorrhagic shock.

Authors:  Yun Zhang; Hang-Ping Yao; Fang-Fang Huang; Wei Wu; Yuan Gao; Zuo-Bing Chen; Zhong-Yan Liang; Ting-Bo Liang
Journal:  Crit Care Med       Date:  2008-12       Impact factor: 7.598

7.  Hydrocortisone prevents immunosuppression by interleukin-10+ natural killer cells after trauma-hemorrhage.

Authors:  Antoine Roquilly; Alexis Broquet; Cédric Jacqueline; Damien Masson; Jean Pierre Segain; Cecile Braudeau; Mickael Vourc'h; Jocelyne Caillon; Frédéric Altare; Regis Josien; Christelle Retière; Jose Villadangos; Karim Asehnoune
Journal:  Crit Care Med       Date:  2014-12       Impact factor: 7.598

8.  Allicin ameliorates intraintestinal bacterial translocation after trauma/hemorrhagic shock in rats: The role of mesenteric lymph node dendritic cell.

Authors:  Yun Zhang; Jian Zhang; Tao Xu; Wei Wu; Fang-Fang Huang; Wen-Qiao Yu; Shao-Yang Zhang; Ting-Bo Liang
Journal:  Surgery       Date:  2016-10-04       Impact factor: 3.982

9.  Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses.

Authors:  Li-Fan Lu; Mark P Boldin; Ashutosh Chaudhry; Ling-Li Lin; Konstantin D Taganov; Toshikatsu Hanada; Akihiko Yoshimura; David Baltimore; Alexander Y Rudensky
Journal:  Cell       Date:  2010-09-17       Impact factor: 41.582

10.  Interferon gamma stabilizes the T helper cell type 1 phenotype.

Authors:  Y Zhang; R Apilado; J Coleman; S Ben-Sasson; S Tsang; J Hu-Li; W E Paul; H Huang
Journal:  J Exp Med       Date:  2001-07-16       Impact factor: 14.307

View more
  3 in total

1.  Antishock Characteristics of Erythrocyte-mediated Endoplasmic Reticulum Stress in Macrophages in Severe Hemorrhagic Shock Environment Based on TLR9-cGAS-STING-IFN Signal Axis.

Authors:  Yi-Qun Kang; Xiao-Hong Yuan; Zhen-Zhou Li; Huan Wang; Xiao-Fang Zhou; Xiao-Xiao Wang; Zi-Wei Zhang; Yu-Feng Feng; Jian-Rong Guo
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 2.  Therapeutic Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles in the Prevention of Organ Injuries Induced by Traumatic Hemorrhagic Shock.

Authors:  Guillaume Valade; Nicolas Libert; Christophe Martinaud; Eric Vicaut; Sébastien Banzet; Juliette Peltzer
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

Review 3.  Innate immunity and immunotherapy for hemorrhagic shock.

Authors:  Qingxia Huang; Song Gao; Yao Yao; Yisa Wang; Jing Li; Jinjin Chen; Chen Guo; Daqing Zhao; Xiangyan Li
Journal:  Front Immunol       Date:  2022-08-25       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.